Press Release

Illumina to Host Inaugural ESG Investor Event on Tuesday, November 16, 2021

SAN DIEGO, Oct. 20, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will host its first Environment, Social and Corporate Governance (ESG) focused investor event at 11:00 am Pacific Time (2:00 pm Eastern Time), Tuesday, November 16, 2021.

Francis deSouza, President and Chief Executive Officer, Sam Samad, Chief Financial Officer, and Sharon Vidal, Global Lead, Corporate Social Responsibility, will be joined by Maggie Lake, journalist and ESG communication specialist, for a presentation and fireside chat for investors, analysts, and other interested parties regarding Illumina's ESG strategy and action plans. 

Conference Call Details
The webcast will begin at 11:00 am Pacific Time (2:00 pm Eastern Time) on Tuesday, November 16, 2021. Interested parties may register for the event in advance through the Investor Info section of Illumina's website under the "company" tab at www.illumina.com.  To ensure timely connection, please join the webcast at least ten minutes before the scheduled start.

A replay of the webcast will be posted on Illumina's website after the event and will be available for at least 30 days following.

About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on TwitterFacebookLinkedInInstagram, and YouTube.

Investors:
Brian Blanchett
+1.858.291.6421
ir@illumina.com
Media:
Dr. Karen Birmingham
+1.646.355.2111
kbirmingham@illumina.com

Cision View original content:https://www.prnewswire.com/news-releases/illumina-to-host-inaugural-esg-investor-event-on-tuesday-november-16-2021-301405053.html

SOURCE Illumina, Inc.

Recent Articles

When CGP uncovers potential hereditary cancer risk
When CGP uncovers potential hereditary cancer risk
Early access users rave about Illumina’s new MiSeq i100 Series
Early access users rave about Illumina’s new MiSeq i100 Series
Trailblazing study shows early CGP leads to better precision treatments
Trailblazing study shows early CGP leads to better precision treatments